Vigabatrin
Vigabatrin is a prescription medication used as an anti-epileptic agent to help control seizures. It comes as a 500 mg oral tablet, manufactured by Zydus Lifesciences Limited under application ANDA215707. This generic version is available for oral use. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Vigabatrin is a prescription medication used as an anti-epileptic agent to help control seizures. It comes as a 500 mg oral tablet, manufactured by Zydus Lifesciences Limited under application ANDA215707. This generic version is available for oral use. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Vigabatrin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Vigabatrin — ANDA 213519 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213519"
}
]
|
| identifier | ANDA213519 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"drug-safety",
"fda",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Vigabatrin |
